Physician profile
William Andrew Mueller, III
NPI 1164574679
$1,379.88
in general payments reported to CMS, 2019-2025
9 companies · $55.56 in 2025
The $55.56 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $198 · 2021: $212 · 2022: $276 · 2023: $219 · 2024: $254 · 2025: $55.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $527.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohorizons Implant Systems INC. | $860.43 | 2019-2024 | Biohorizons |
| Henry Schein, INC. | $164.28 | 2021-2024 | |
| Harrow Eye, LLC | $125.00 | 2024 | Iheezo |
| Dentsply Sirona INC | $66.87 | 2023 | Suresmile |
| Orapharma, A Division of Bausch Health US, LLC | $58.10 | 2019-2024 | Arestin |
| Solventum Corporation | $55.56 | 2025 | 3m Filtek, 3m Relyx, 3m Clinpro |
| Philips North America LLC | $30.16 | 2019-2020 | |
| Voco America INC. | $9.93 | 2023 | Profluorid L, Admira Fusion, Futurabond U |
| Align Technology, INC. | $9.55 | 2023 | Invisalign |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mueller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.